Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers April 24, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - April 24, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

4/17/17 - "Chlorine Dioxide Generator" in Patent Application Approval Process (USPTO 20170088420)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Ozawa, Fumihiro; Asada, Shigeo; Nakahara, Koichi; Taguchi, Kazuhiko, filed on December 13, 2016, was made available online on April 6, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent applica
4/17/17 - $125.88 Billion Topical Drug Delivery Market by Product Type, Route of Administration - Global Forecast to 2021 - Research and Markets
Research and Markets has announced the addition of the "Topical Drug Delivery Market by Product Type, Route of Administration- Global Forecast to 2021" report to their offering. The topical drug delivery market is expected to reach USD 125.88 Billion by 2021 from USD 92.40 Billion in 2016 at a CAGR of 6.4% during the forecast period. Major factors
4/17/17 - Acadia Pharmaceuticals Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities (Mar. 31, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on March 31, 2017. The SEC file number is 0001415889-17-000525.. A U.S. Securities and Exchange Commission fil
4/17/17 - Acadia Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Mar. 31, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on March 31, 2017. The SEC file number is 0001415889-17-000528.. A U.S. Securities and Exchange Commission fil
4/17/17 - Acadia Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Mar. 31, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on March 31, 2017. The SEC file number is 0001415889-17-000524.. A U.S. Securities and Exchange Commission fil
4/17/17 - AcelRx Pharmaceuticals Presenting Comprehensive DSUVIA Clinical Trial Results at ASRA's Annual Regional Anesthesiology and Acute Pain Medicine Meeting
By a News Reporter-Staff News Editor at Clinical Trials Week- AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain, announced that efficacy and integrated safety results from the DSUVIA? clinical program would
4/17/17 - Acorda Therapeutics Inc. Files SEC Form 8-K, Current Report (Mar. 31, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acorda Therapeutics Inc. was posted on March 31, 2017. The SEC file number is 0001564590-17-005755.. A U.S. Securities and Exchange Commission filing
4/17/17 - Acura Pharmaceuticals, Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-k Item 405] (Mar. 31, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acura Pharmaceuticals, Inc. was posted on March 31, 2017. The SEC file number is 0001144204-17-018146.. A U.S. Securities and Exchange Commission fil
4/17/17 - Acura Pharmaceuticals, Inc. Files SEC Form 8-K, Current Report (Mar. 31, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acura Pharmaceuticals, Inc. was posted on March 31, 2017. The SEC file number is 0001144204-17-018205.. A U.S. Securities and Exchange Commission fil
4/17/17 - Aeterna Zentaris Inc. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16] (Mar. 30, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aeterna Zentaris Inc. was posted on March 30, 2017. The SEC file number is 0001104659-17-020245.. A U.S. Securities and Exchange Commission filing is
4/17/17 - Aeterna Zentaris Mails Management Information Circular in Connection with Annual Meeting of Shareholders
By a News Reporter-Staff News Editor at Pharma Business Week Aeterna Zentaris Inc. announced that it has mailed a Notice of Meeting and Management Information Circular to the shareholders of record as of March 20, 2017 in connection with its Annual Meeting of shareholders to be held at the offices of Norton Rose Fulbright Canada, 1 Place Ville-Ma
4/17/17 - Agenus Commences Phase 1 Trial with Neoantigen Cancer Vaccine AutoSynVax
By a News Reporter-Staff News Editor at Clinical Trials Week- Agenus Inc., an immuno-oncology company with a clinical stage pipeline of immune checkpoint antibodies and cancer vaccines, announced that the first patient has been dosed in a Phase 1 clinical trial of AutoSynVax?, Agenus' neoantigen vaccine. The trial is intended to pave the way fo
4/17/17 - AID-TEC is developing unique bandage solutions that contains a breakable capsule; when broken, the capsule releases a fresh dose of a medication into the pad.
AID-TEC is developing unique bandage solutions that contains a breakable capsule; when broken, the capsule releases a fresh dose of a medication into the pad. AID-TEC is a uniquely engineered and designed bandage which, using a unique and patented delivery system. AID-TEC's patent is a unique bandage that contains a breakable capsule; when broken,
4/17/17 - Akebia Therapeutics, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Apr. 4, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Akebia Therapeutics, Inc. was posted on April 4, 2017. The SEC file number is 0001562180-17-001429.. A U.S. Securities and Exchange Commission filing
4/17/17 - Akebia Therapeutics, Inc. Files SEC Form CT ORDER, Confidential Treatment Order (Mar. 31, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Akebia Therapeutics, Inc. was posted on March 31, 2017. The SEC file number is 9999999997-17-005213.. A U.S. Securities and Exchange Commission filin
4/17/17 - Alexion Pharmaceuticals Inc. Files SEC Form DEF 14A, Other Definitive Proxy Statements (Mar. 31, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alexion Pharmaceuticals Inc. was posted on March 31, 2017. The SEC file number is 0000899866-17-000078.. A U.S. Securities and Exchange Commission fi
4/17/17 - Alexion Pharmaceuticals Inc. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material (Mar. 31, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alexion Pharmaceuticals Inc. was posted on March 31, 2017. The SEC file number is 0000899866-17-000080.. A U.S. Securities and Exchange Commission fi
4/17/17 - Alexion to Report First Quarter 2017 Results on Thursday, April 27, 2017
By a News Reporter-Staff News Editor at Pharma Business Week Alexion Pharmaceuticals, Inc. announced that the Company will report its financial results for the first quarter ended March 31, 2017 on Thursday, April 27, 2017 before the US financial markets open. Following the release of the financial results, Alexion management will conduct a confe
4/17/17 - Alexza Pharmaceuticals Inc. Files SEC Form CT ORDER, Confidential Treatment Order (Mar. 31, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alexza Pharmaceuticals Inc. was posted on March 31, 2017. The SEC file number is 9999999997-17-005238.. A U.S. Securities and Exchange Commission fil
4/17/17 - Alkermes Plc. Files SEC Form 8-K, Current Report (Mar. 31, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alkermes Plc. was posted on March 31, 2017. The SEC file number is 0001520262-17-000012.. A U.S. Securities and Exchange Commission filing is a forma
4/17/17 - Alkermes Plc. Files SEC Form PRE 14A, Other Preliminary Proxy Statements (Mar. 31, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alkermes Plc. was posted on March 31, 2017. The SEC file number is 0001558370-17-002374.. A U.S. Securities and Exchange Commission filing is a forma
4/17/17 - Allergan Plc Files SEC Form 11-K, Annual Report of Employee Stock Purchase, Savings And Similar Plans (Mar. 30, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Allergan Plc was posted on March 30, 2017. The SEC file number is 0001193125-17-104084.. A U.S. Securities and Exchange Commission filing is a formal
4/17/17 - Allergan Plc Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Apr. 4, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Allergan Plc was posted on April 4, 2017. The SEC file number is 0001179110-17-005549.. A U.S. Securities and Exchange Commission filing is a formal
4/17/17 - Allergan Reports Topline Phase II Data Supporting Advancement of BOTOX onabotulinumtoxinA for the Treatment of Major Depressive Disorder MDD
By a News Reporter-Staff News Editor at Mental Health Weekly Digest Allergan plc, a leading global pharmaceutical company announced topline data from a Phase II study with Major Depressive Disorder. Given our in-depth and extensive clinical trial experience in CNS including depression, we plan to move forward and develop a phase 3 program for a p
4/17/17 - Allergan's Trademark Application for "XBRIA" Filed
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "XBRIA" by Susan J. Hinchey, representing Allergan. The owner/registrar information for this application is: Susan J. Hinchey, Allergan, 2525 Dupont Drive, Irv
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415